Replies to post #142563 on Avid Bioservices Inc (CDMO)

[porkchop11]

Jake, when did your opinion about all of this change, LOL!

You know you'll be dancing the jig with me, wook and loof when PPHM hits it big!

imo, and pass the korn likker and hopium pills...

porkchop11 :0

[epcjmc]

Mr. Dogman -

Since you knew the good Dr. Thorpe, I have been trying to find some information on the nature/cause of his death - ie, cancer, heart attack, walking accross the street getting hit by a car, accidential drowning, etc. I have not been able to determine this, in fact, about all I can find is that he sold a house at one time.

Is this taboo to discuss since this topic is not specifically related to PPHM, or is it?

By the way, I do not suscribe to the grassy knoll, roswell, Lochness Monster, or Bigfoot theories. I would just like to know more about the guy - rest his soul.

[biopharm]

I agree that under normal circumstances a more diverse BOD would be welcomed by shareholders of 99% of public companies. That percentage drops though when we are talking biotech, a small biotech that is easily manipulated by Hedge Funds which is the reason for me showing the correlation to how manipulative Hedge Funds may be and can be towards a small biotech.

This Cramer video just shows "some" of the tactics that are used by Hedge Funds Cramer mentions at the 1 min 30 sec mark and states: "I'm not going to say it on TV" ...

I believe that percentage drops further when you then take Big Pharmas agenda of holding drugs back or even being able to buy the votes of the BOD of some small biotechs.

What happens next is the small biotechs are "forced" to decide if they are not allowed to advance fairly in a legal manner....they may have to shut down or give in to Big Pharma....in some way.....

Now all these are with small biotechs that have a drug for maybe just one indication and they are unable to spend 10x more to fend off Big Pharma because their final return is not worth it so hence....shut down shop or make a weak deal with someone or they "try" to keep their payroll for a couple more years because even that weak deal they were offered was truly weak.

Next...the percentage drops even more when not just a drug is discovered but rather a "platform" with great potential and safety and a novel MOA of targeting PS where we have all seen the historic results.

Once Big Pharma realized they cant buy or hold back Bavituximab...
Once Big Pharma realized they cant buy the BOD...
Once Big Pharma realized they cant make a cheap deal with Peregrine.....

Plan Fargo like trials... finally is forced to be initiated by Big Pharma

.....after all this.....the percentage is very low of those shareholders that want to kick out the BOD when all they have been doing is not accepting a weak deal from a BP and not selling out to a BP....and not selling off our IP and now we sit and wait..... and give hope to that next small biotech in how they should move forward if they believe a "paradigm shifting" platform of technologies is to be found again. Peregrine will be the talk of many future small biotechs that will try to follow in their footsteps and hold onto every leveraged inch of your IP as you possibly can because its the only way to maximixe shareholder value.

I see that shareholder value reaching new highs ....in short time and last minute offers and deals will be happening. There is NO WAY a BP can just let this slip by and for many of them it did slip by last year and they may be thanking Fargo which allowed them to gave a 2nd chance at making their final offer ......one more time.

K&L Gates ..... will create a way for the deal to be passed...imo